Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q2 2020 · 10-Q
Revenue$2.97M$2.97M−1.7% vs Q2 2019 Net Income-$1.13M-$1.13MN/M vs Q2 2019 EPS Diluted-$0.18-$0.18N/M vs Q2 2019 Gross Profit$2,618,508−2.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived-$700,172N/M Free Cash Flowderived-$700,172N/M Margins · derivedGross margin88.2%−0.7 pt vs Q2 2019
Operating margin-36.4%−25.7 pt vs Q2 2019
Net margin-38.1%−26.4 pt vs Q2 2019
ended Jun 30, 2020 · filed Aug 13, 2020 · 44 d after period end